RSS Feed for Latest Medical Headlines on RxPG News

Medical Research Health Special Topics World

 
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
  Arthritis
   Ankylosing Spondylitis
   Osteoarthritis
   Rheumatiod Arthritis
  Scleroderma
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate
Search

Latest Research : Rheumatology : Arthritis
  Last Updated: May 15, 2012 - 7:32:29 AM

Latest Research : Rheumatology : Arthritis : Rheumatiod Arthritis
DNA-covered submicroscopic bead used to deliver genes to treat rheumatoid arthritis
A DNA-covered submicroscopic bead used to deliver genes or drugs directly into cells to treat disease appears to have therapeutic value just by showing up, researchers report.
In an animal model of rheumatoid arthritis, the enhanced expression of indoleomine 2,3 dioxygenase, or IDO, significantly reduced the hallmark limb joint swelling and inflammation of this debilitating autoimmune disease, researchers report in the study featured on the cover of The Journal of Immunology.


May 15, 2012 - 7:23:08 AM

Latest Research : Rheumatology : Arthritis
Rilonacept significantly reduced acute gout flares during uric acid-lowering therapy
A phase II clinical trial, published in Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR), found that rilonacept, an inhibitor of the protein interleukin-1 (IL-1), significantly reduced acute gout flares that occur when initiating uric acid-lowering therapy.
Jan 5, 2012 - 2:37:46 AM

Latest Research : Rheumatology : Arthritis : Ankylosing Spondylitis
Advances in genetics related to ankylosing spondylitis
Work done in part by researchers at The University of Texas Health Science Center at Houston has led to the discovery of two new genes that are implicated in ankylosing spondylitis (AS), an inflammatory and potentially disabling disease.
Jan 10, 2010 - 2:50:50 PM

Latest Research : Rheumatology : Arthritis
Is Devil's Claw the key to treating arthritis?
Deep in Africa's Kalahari desert lies the Devil's Claw, a plant that may hold the key to effective treatments for arthritis, tendonitis and other illnesses that affect millions each year.
Aug 17, 2009 - 3:48:25 PM

Latest Research : Rheumatology : Arthritis
High birth weight - risk for rheumatoid arthritis
People who have a birthweight over 10 pounds are twice as likely to develop rheumatoid arthritis when they are adults compared to individuals born with an average birthweight, according to a study published by researchers from Hospital for Special Surgery online in advance of print in the Annals of the Rheumatic Diseases.
Jun 30, 2008 - 8:40:12 AM

Latest Research : Rheumatology : Arthritis : Osteoarthritis
Matrilin-3 gene discovered to prevent onset of osteoarthritis
A gene that is associated with osteoarthritis and skeletal deformities in people has been shown to be responsible for preventing the onset of osteoarthritis in adult mice, according to a recent study led by Rhode Island Hospital. The matrilin-3 gene plays a role in early bone development, controls bone mineral density in adulthood and prevents osteoarthritis later in life.
Jul 24, 2006 - 7:17:00 PM

Latest Research : Rheumatology : Arthritis
Rituximab halts damage to joints
New data, presented today at the Annual European Congress of Rheumatology show for the first time that a rheumatoid arthritis (RA) treatment, rituximab, is able to significantly inhibit the structural damage to joints caused by RA in patients who have long-standing disease and an inadequate response to one or more TNF (Tumour Necrosis Factor) inhibitors.
Jun 22, 2006 - 5:23:00 PM

Latest Research : Rheumatology : Arthritis
Tocilizumab effective in systemic juvenile idiopathic arthritis (sJIA)
A new study has confirmed significant improvements after treatment with tocilizumab amongst children with systemic juvenile idiopathic arthritis (sJIA), who do not tolerate or have an inadequate response to conventional therapies. Professor Shumpei Yokota presented the encouraging results of the first double-blind, placebo controlled trial for tocilizumab at the Annual European Congress of Rheumatology in Amsterdam today (Thursday 22 June)
Jun 22, 2006 - 4:44:00 PM

Latest Research : Rheumatology : Arthritis : Rheumatiod Arthritis
Unfavourable blood fat levels predict rheumatoid arthritis up to 10 years later
An unfavourable ratio of blood fats could herald the development of the inflammatory joint disease rheumatoid arthritis up to 10 years later, suggests research published ahead of print in the Annals of Rheumatic Diseases.
Jun 5, 2006 - 4:59:00 PM

Latest Research : Rheumatology : Arthritis
Role of inflammatory leukocytes in extending tissue damage
Documented in extensive studies, backed by the anecdotal evidence of professional athletes, impact injury to joints causes degeneration of cartilage. In most cases, the eventual result is the pain, stiffness, and compromised mobility of osteoarthritis (OA). Yet, questions remain surrounding the role of the inflammatory system in the cartilage destruction following mechanical trauma.
Apr 30, 2006 - 11:29:00 PM

Latest Research : Rheumatology : Arthritis
Rituximab achieves remission in patients resistant to conventional DMARDs
Drugs aimed at suppressing inflammation-provoking cytokines--specifically those linked to T-cells--have improved the treatment of rheumatoid arthritis (RA), a chronic, inflammatory autoimmune disease. Still, the frequency of remission achieved by these biologic agents remains below 50 percent. To increase the success rate of biologic therapy for RA patients, researchers have honed in on a new target: the B cell.
Apr 30, 2006 - 11:13:00 PM

Latest Research : Rheumatology : Arthritis
New hope for tissue regeneration and joint repair
Inflammation, cartilage and bone erosions, joint destruction--that's the typical progression of arthritis and most rheumatic diseases. While inflammation may be controlled, and perhaps even eliminated, with early aggressive treatment, few therapeutic approaches offer hope for repairing tissue once the damage has been done. One promising strategy is the use of mesenchymal stem cells (MSCs). MSCs are capable of extensive self-renewal and adaptable to forming all kinds of connective tissues. While detected in several adult human tissues, MSCs have traditionally been obtained from bone marrow, an invasive, painful, and costly process.
Mar 29, 2006 - 1:13:00 PM

Latest Research : Rheumatology : Arthritis
Fighting inflammation with targeted liposomal therapy
Vascular endothelial cells (VECs) form the walls of blood vessels and play a critical role in inflammation. In rheumatoid arthritis (RA), VECs interact with cytokines, proteins that regulate immune response, and allow inflammation to persist, escalate, and progressively damage tissue, and joints. Recognized as potent inflammation inhibitors, corticosteroids work to control the expression of cytokines, adhesion molecules and the growth of endothelial cells. The potential of these drugs, however, has been restricted by their considerable toxicity and short half-life.
Mar 29, 2006 - 1:08:00 PM

Latest Research : Rheumatology : Arthritis
Snake venom could ease arthritis pain
Snake venom could ease the debilitating pain from arthritis, say scientists.
Mar 29, 2006 - 12:56:00 PM

Latest Research : Rheumatology : Arthritis
Sodium Hyaluronate Can Fill the gap left by Cox-2 inhibitors
After the rise in safety concerns surrounding Vioxx and other Cox-2 inhibitors, people suffering from chronic shoulder pain were left with just two therapy options at opposite extremes - take Advil, or have surgery. But a new study from Columbia University Medical Center shows that sodium hyaluronate, a drug that is FDA-approved for osteoarthritis of the knee, is also effective for shoulder pain.
Mar 25, 2006 - 3:52:00 PM

Latest Research : Rheumatology : Arthritis : Rheumatiod Arthritis
Patients with severe Rheumatoid arthritis are at increased risk of developing lymphoma - New Study
An inflammatory disease of the immune system, rheumatoid arthritis (RA) is associated with increased occurrence of lymphoma--or cancers of the lymphatic system, which plays an integral role in the body's ability to fight infection. While various studies have affirmed this link, none have been able to pinpoint the specific effects of disease activity on lymphoma risk, let alone distinguish them from the effects of disease treatment.
Feb 27, 2006 - 5:54:00 PM

Latest Research : Rheumatology : Arthritis : Osteoarthritis
The link between meniscal damage and early onset osteoarthritis
This C-shaped tissue has many functions in the knee, including load bearing, shock absorption, and stability enhancement. The onset of knee OA after meniscectomy, the surgical removal of all or part of a torn meniscus, is fairly common and traditionally considered a result of the joint injury that leads to the operation in the first place.
Feb 27, 2006 - 5:49:00 PM

Latest Research : Rheumatology : Arthritis
Selective COX-2 inhibitors may still be best option for arthritis
Scientists believe that despite the current concerns around anti-inflammatory drugs like Vioxx, they may still be the best option for treating some forms of arthritis.
Jan 19, 2006 - 5:54:00 PM

Latest Research : Rheumatology : Arthritis : Rheumatiod Arthritis
Support for combination therapy for achieving remission of early rheumatoid arthritis
Two-year study of patients with early, aggressive disease demonstrates significantly superior results of anti-TNF plus DMARD therapy over either therapy alone

Jan 4, 2006 - 5:35:00 AM

Latest Research : Rheumatology : Arthritis : Rheumatiod Arthritis
Role of Type II Collagen in rheumatoid arthritis
Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic inflammation of the joints, which gradually erodes the cartilage and bone. The agents of destruction include inflammatory cells, cytokines, and protein-degrading enzymes known as matrix metalloproteinases (MMPs). The vicious cycle begins when inflammatory cells infiltrate the tissue lining the joints and consume excess oxygen. In addition to unleashing MMPs, the oxidative stress provokes non-enzymatic glycation – a chemical binding of sugar molecules and proteins. Telltale signs of glycation have been found in blood, urine, and synovial fluid of RA patients.
Dec 5, 2005 - 4:11:00 AM

Latest Research : Rheumatology : Arthritis
Study shows long-term benefits of initial combination therapy in RA
A progressive, inflammatory disease affecting the joints and organs, rheumatoid arthritis (RA) claims more than two million Americans, mostly women over age 40, among its victims. While a cure has yet to be found, the treatment of RA patients has changed considerably over the last two decades. Today, the goal of therapy is not simply symptom relief, but the prevention of long-term structural damage and functional decline. Toward this end, various disease-modifying antirheumatic drugs (DMARDs) have been proven effective in clinical trials, on their own and in tandem with various tumor necrosis factor (TNF) antagonists. While the recent increase in therapeutic options offers much promise, it has left doctors grappling with the question: What is the best treatment strategy for a patient newly diagnosed with RA?
Oct 30, 2005 - 2:16:00 PM

Latest Research : Rheumatology : Arthritis
Exercise May Strengthen Knee Cartilage in OA Patients
Osteoarthritis (OA) is the leading cause of disability among adults. As the population ages, increased intervention efforts are vital to controlling the individual and public health toll of this chronic, crippling joint disease. Along with early diagnosis, moderate exercise is one of the most effective ways to reduce pain and improve function in patients with OA of the knee and hip. Yet, more than 60 percent of U.S. adults with arthritis fail to meet the minimum recommendations for physical activity.
Oct 30, 2005 - 2:08:00 PM

Latest Research : Rheumatology : Arthritis
Synthetic protein PLAD shows potential in arthritis treament
A lab-made version of a human protein alleviates symptoms of both acute and chronic arthritis in mice and could be the basis for a new arthritis drug for people, report scientists from the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH). The protein prevents the assembly of a cell surface receptor, thus blocking transmission of chemical signals that lead to arthritis symptoms.
Oct 4, 2005 - 8:02:00 PM

Latest Research : Rheumatology : Arthritis : Rheumatiod Arthritis
Is the Disease Course of Rheumatoid Arthritis Becoming Milder?
Study affirms improving trend in the course of disease activity over the last decade, coinciding with more aggressive treatment strategies
Sep 4, 2005 - 8:14:00 AM

Latest Research : Rheumatology : Arthritis
New findings on “menopausal arthritis”
One of the most effective new treatments for breast cancer is a hormone therapy. Aromatase inhibitors work by powerfully blocking the conversion of androgen precursors into estrogens, which lowers estradiol levels in the bloodstream and estrogen levels in peripheral tissues. Because aromatase inhibitors reduce the rates of recurrence in women with early-stage postmenopausal breast cancer, these agents are not only becoming widely used in breast cancer treatment, but also being explored for their potential to prevent the disease in women at high risk.
Sep 4, 2005 - 7:23:00 AM

Latest Research : Rheumatology : Arthritis
Brightly-coloured fruit and veg may protect against arthritis
Researchers from The University of Manchester's Medical School have discovered that eating more brightly-coloured fruits and vegetables like oranges, carrots and sweetcorn may help reduce the risk of developing inflammatory disorders like rheumatoid arthritis.
Aug 18, 2005 - 2:17:00 AM

Latest Research : Rheumatology : Arthritis
Biologic drug adalimumab is effective in treating rheumatoid arthritis
There is good evidence that adding adalimumab (Humira) to the treatment of people with long-standing rheumatoid arthritis is more effective than using oral methotrexate alone.
Jul 20, 2005 - 3:07:00 PM

Latest Research : Rheumatology : Arthritis
Losing a pound results in a 4-pound reduction in knee-joint load for each step
The leading cause of disability in the United States, osteoarthritis (OA) is a complex, degenerative joint disease with several established risk factors. For OA of the knee, the most important modifiable risk factor is obesity. Both the American College of Rheumatology and the European League Against Rheumatism recommend weight loss and exercise to reduce the painful and incapacitating symptoms of knee OA.
Jun 29, 2005 - 1:04:00 PM

Latest Research : Rheumatology : Arthritis
Study shows effectiveness of doxycycline in slowing osteoarthritis progression

Jun 29, 2005 - 1:02:00 PM

Latest Research : Rheumatology : Arthritis
Knee injury causes decrease in lubrication
Researchers have found an association between inflammation from knee injuries and a progressive loss of joint lubrication, which may predispose people to arthritis. They have also found a way to quantify how much lubrication is lost following injury.
Jun 3, 2005 - 4:57:00 PM

Latest Research : Rheumatology : Arthritis
Study links TNF to androgen deficiency in rheumatoid arthritis
A protein involved in multiple cell functions, tumor necrosis factor (TNF) is perhaps best known for provoking destructive inflammation. Recently, drugs blocking the action of TNF have shown promise in the early treatment of rheumatoid arthritis (RA).
Jun 2, 2005 - 3:59:00 PM

Latest Research : Rheumatology : Arthritis : Ankylosing Spondylitis
Continuous NSAID use beneficial in ankylosing spondylitis
A widely under-recognized form of arthritis, ankylosing spondylitis (AS) is a chronic, progressive disease targeting the spine. Commonly striking in young adulthood, before age 35, AS causes inflammation, pain, and stiffness in the spinal joints--the vertebrae--and the sacroiliac joint, where the spinal column meets the pelvis. In advanced cases, this disease can result in deforming, crippling spinal fusion and organ damage. According to expert estimates, AS afflicts at least half a million people in the United States.
Jun 2, 2005 - 3:49:00 PM

<< prev next >>

 
Headlines
Health  
Gathering information about food is not top priority for individuals with high metabolisms
NIH renews funding for University of Maryland vaccine research
DHA-enriched formula in infancy linked to positive cognitive outcomes in childhood
New IOM report lays out plan to determine effectiveness of obesity prevention efforts
Vitamin D supplementation may delay precocious puberty in girls
Study: Pedometer program helps motivate participants to sit less, move more
Fish oil may stall effects of junk food on brain
Intake of low energy dense food better than skipping meals
Inaugural IOF Olof Johnell Science Award presented to Professor Harry Genant
Molecular hub links obesity, heart disease to high blood pressure
Healthcare  
Healthcare experts from UK and India meet at the UK Parliament to discuss ways to improve health care in India, UK
Flu pandemic infected one in five
Stigma preventing leprosy-cured from getting jobs
Measles, Mumps make a comeback in US
Melinda Gates calls on Akhilesh Yadav
'Movies, TV impact tobacco users more than newspapers'
Rockland to open three new hospitals in NCR
Spice Global enters healthcare business with hospital in Delhi
Delhi to expedite recruitment of doctors
India adds spice to US life, keeps it healthy
Latest Research  
How do consumers see a product when they hear music?
Drug activates virus against cancer
Bone loss associated with increased production of ROS
Sound preconditioning prevents ototoxic drug-induced hearing loss in mice
Crystal methamphetamine use by street youth increases risk of injecting drugs
Johns Hopkins-led study shows increased life expectancy among family caregivers
Moderate to severe psoriasis linked to chronic kidney disease, say experts
Licensing deal marks coming of age for University of Washington, University of Alabama-Birmingham
Simple blood or urine test to identify blinding disease
Physician job satisfaction driven by quality of patient care
Medical News  
NHRC issues notice to Kerala over infant deaths
Advanced breast cancer detecting machine comes to India
'Dispel myths about vitiligo'
NHRC summons Odisha chief secretary
Woman dies of swine flu in UP
Maharashtra, GE to modernise rural health care
Hypertension: India's silent killer
Need cautious effort to eradicate polio: Experts
Ayurveda experts develop online personalised health regimen
Soon a detailed study on 'diabesity': Doctors
Special Topics  
MPs express anguish at Delhi gang-rape, Shinde assures fast trial
Worrying rise in number of medical students in prostitution over last 10 years
Behold India's unfolding democratic revolution
Chinese woman cuts open her belly to save surgery cost
Improved Sense of Smell Produced Smarter Mammals
Two-year-old world's first to have extra DNA strand
172,155 kidney stones removed from one patient!
'Primodial Soup' theory for origin of life rejected in paper
Human species could have killed Neanderthal man
History, geography also seem to shape our genome

All rights reserved by RxPG
Contact Us